
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The interplay between m6A RNA methylation and noncoding RNA in cancer
Shuai Ma, Chen Chen, Xiang Ji, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 513
Shuai Ma, Chen Chen, Xiang Ji, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 513
Showing 1-25 of 513 citing articles:
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 424
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 424
Role of m6A RNA methylation in cardiovascular disease (Review)
Yuhan Qin, Linqing Li, Erfei Luo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 1958-1972
Open Access | Times Cited: 230
Yuhan Qin, Linqing Li, Erfei Luo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 1958-1972
Open Access | Times Cited: 230
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Wei Huang, Tian-Qi Chen, Ke Fang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 187
Wei Huang, Tian-Qi Chen, Ke Fang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 187
The biological function of m6A demethylase ALKBH5 and its role in human disease
Jinyan Wang, Jinqiu Wang, Quan Gu, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 151
Jinyan Wang, Jinqiu Wang, Quan Gu, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 151
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway
Xuehan Bi, Xiao Lv, Dajiang J. Liu, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 335-349
Closed Access | Times Cited: 145
Xuehan Bi, Xiao Lv, Dajiang J. Liu, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 335-349
Closed Access | Times Cited: 145
The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene
Shuiping Liu, Qiujie Li, Guohua Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 143
Shuiping Liu, Qiujie Li, Guohua Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 143
Liquid–liquid phase separation in tumor biology
Xuhui Tong, Rong Tang, Jin Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 136
Xuhui Tong, Rong Tang, Jin Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 136
N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization
Chen Chen, Weitang Yuan, Quanbo Zhou, et al.
Theranostics (2021) Vol. 11, Iss. 9, pp. 4298-4315
Open Access | Times Cited: 124
Chen Chen, Weitang Yuan, Quanbo Zhou, et al.
Theranostics (2021) Vol. 11, Iss. 9, pp. 4298-4315
Open Access | Times Cited: 124
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma
Ruichao Chai, Yuzhou Chang, Xin Chang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 123
Ruichao Chai, Yuzhou Chang, Xin Chang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 123
m6A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2‐mediated IGF1R mRNA stabilization
Chuandong Lang, Chi Yin, Kai‐Yuan Lin, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 6
Open Access | Times Cited: 120
Chuandong Lang, Chi Yin, Kai‐Yuan Lin, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 6
Open Access | Times Cited: 120
LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC
Xinyi Qian, Juze Yang, Qiongzi Qiu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 112
Xinyi Qian, Juze Yang, Qiongzi Qiu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 112
FTO modifies the m6A level of MALAT and promotes bladder cancer progression
Le Tao, Xingyu Mu, Haige Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 106
Le Tao, Xingyu Mu, Haige Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 106
The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma
Li Liu, Jiangtu He, Guifeng Sun, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 101
Li Liu, Jiangtu He, Guifeng Sun, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 101
Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA
Li Zhou, Jingwen Jiang, Zhao Huang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 101
Li Zhou, Jingwen Jiang, Zhao Huang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 101
The roles and mechanism of m6A RNA methylation regulators in cancer immunity
Lu Chen, Ying He, Jinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114839-114839
Open Access | Times Cited: 100
Lu Chen, Ying He, Jinyu Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114839-114839
Open Access | Times Cited: 100
N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells
Zhihua Liu, Nanxin Zheng, Juan Li, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100886-100886
Closed Access | Times Cited: 83
Zhihua Liu, Nanxin Zheng, Juan Li, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100886-100886
Closed Access | Times Cited: 83
SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine
Zuwei Wang, Jingjing Pan, Jian-Fei Hu, et al.
Cell Reports (2022) Vol. 39, Iss. 6, pp. 110813-110813
Open Access | Times Cited: 77
Zuwei Wang, Jingjing Pan, Jian-Fei Hu, et al.
Cell Reports (2022) Vol. 39, Iss. 6, pp. 110813-110813
Open Access | Times Cited: 77
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
Vincenza Ylenia Cusenza, Annalisa Tameni, Antonino Neri, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 43
Vincenza Ylenia Cusenza, Annalisa Tameni, Antonino Neri, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 43
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
RNA methylations in human cancers
Xiao Han, Mengke Wang, Yongliang Zhao, et al.
Seminars in Cancer Biology (2020) Vol. 75, pp. 97-115
Closed Access | Times Cited: 133
Xiao Han, Mengke Wang, Yongliang Zhao, et al.
Seminars in Cancer Biology (2020) Vol. 75, pp. 97-115
Closed Access | Times Cited: 133
m6A modification in RNA: biogenesis, functions and roles in gliomas
Yuhao Zhang, Xiuchao Geng, Qiang Li, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 126
Yuhao Zhang, Xiuchao Geng, Qiang Li, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 126
RNA-Binding Proteins as Important Regulators of Long Non-Coding RNAs in Cancer
Katharina Jonas, George A. Călin, Martin Pichler
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2969-2969
Open Access | Times Cited: 111
Katharina Jonas, George A. Călin, Martin Pichler
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2969-2969
Open Access | Times Cited: 111
Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types
Sipeng Shen, Ruyang Zhang, Yue Jiang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 87
Sipeng Shen, Ruyang Zhang, Yue Jiang, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 87
The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer
Yu Chen, Emory Zitello, Rui Guo, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 85
Yu Chen, Emory Zitello, Rui Guo, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 85